---
title: "Matinas BioPharma soars 37% on heavy volume during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293967683.md"
description: "Matinas BioPharma (MTNB) jumped 37% to $0.33 in regular trading on volume of 194M shares."
datetime: "2026-07-27T19:40:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293967683.md)
  - [en](https://longbridge.com/en/news/293967683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293967683.md)
---

# Matinas BioPharma soars 37% on heavy volume during regular trading

Matinas 生物制药 (MTNB.US) 盘中急涨**37.32%**，现报**0.3315**美元。

公司日内成交量达 1.94 亿股，盘前一度飙升 78%，延续近期强势波动。此前消息显示该股早盘已触发多次异动警报，资金活跃度显著提升。

### Related Stocks

- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)

## Related News & Research

- [If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/296125166.md)
- [RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers](https://longbridge.com/en/news/296039942.md)
- [AstraZeneca: Tagrisso Plus Orpathys Phase III Trial Shows PFS, OS Improvements In EGFRm Lung Cancer](https://longbridge.com/en/news/296071807.md)
- [Show Me The Money: Did You Miss CGEM's Rally? Here's What Comes Next](https://longbridge.com/en/news/295789917.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)